---
title: "HELON released its 2024 annual performance, with a net profit attributable to shareholders of 43.8807 million yuan, a year-on-year decrease of 5.38%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236403042.md"
description: "HELON released its 2024 annual report, with operating revenue of 1.055 billion yuan, a year-on-year increase of 2.43%. The net profit attributable to the parent company was 43.8807 million yuan, a year-on-year decrease of 5.38%; the net profit after deducting non-recurring gains and losses was 42.8941 million yuan, a year-on-year decrease of 6.76%. The basic earnings per share were 0.05 yuan"
datetime: "2025-04-17T11:19:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236403042.md)
  - [en](https://longbridge.com/en/news/236403042.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236403042.md)
generator: "portal-rs"
---

# HELON released its 2024 annual performance, with a net profit attributable to shareholders of 43.8807 million yuan, a year-on-year decrease of 5.38%

According to the Zhitong Finance APP, HELON (000677.SZ) released its annual report for 2024. During the reporting period, the company achieved operating revenue of 1.055 billion yuan, a year-on-year increase of 2.43%. The net profit attributable to shareholders of the listed company was 43.8807 million yuan, a year-on-year decrease of 5.38%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 42.8941 million yuan, a year-on-year decrease of 6.76%. The basic earnings per share were 0.05 yuan

### Related Stocks

- [000677.CN](https://longbridge.com/en/quote/000677.CN.md)

## Related News & Research

- [Nearly 25K pounds of frozen buffalo chicken recalled over inspection lapse](https://longbridge.com/en/news/297124023.md)
- [MSC halts Russian Black Sea service after drone attack, Bloomberg News reports](https://longbridge.com/en/news/297066548.md)
- [Heidelberg Pharma, Huadong Medicine expand ADC collaboration to develop new drug candidates](https://longbridge.com/en/news/297291658.md)
- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)
- [Forte Secures TRY 43.5 Million Defense Order from Public Institution](https://longbridge.com/en/news/297044221.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**